biomedicina slovenica


pr=Bajetta : 3

  1. Cappelletti V; Gariboldi M; De Cecco; Toffanin S; Reid JF; Lusa L; Bajetta E; Celio L; Greco M; Fabbri A; Pierotti MA; Daidone MG
    Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer
    2008
  2. De Cecco L; Cappelletti V; Lusa L; Reid JF; Gariboldi M; Bajetta E; Celio L; Greco M; Daidone MG; Pierotti MA
    Gene expression profile associated to responsitivity to neoadjuvant antiestrogen treatment with toremifene in elderly breast cancer patients
    2005
  3. Bajetta E; Dirix LY; Fein LE; Jones SE; Červek J; Kaufmann M; Fowst C; Polli A; di Salle E; Massimini G
    Survival advantage of exemestane (EXE, aromasin) over megestrol acetate (MA) in postmenopausal women with advanced breast cancer (ABC) refractory to tamoxifen (TAM): results of a phase III randomized double-blind study
    1999


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics